ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023
Total of 6 abstracts accepted for publication in Kidney Week 2023 program
WINSTON-SALEM, N.C., Oct. 30, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic
kidney disease (CKD), today announced that the Company will present four posters discussing investigations into the mechanism of action and clinical outcomes observed with REACT (rilparencel) at
the upcoming American Society of Nephrology’s (ASN) Kidney Week being held on November 2-5, 2023, in Philadelphia, PA.
The titles for the accepted abstracts are provided below and accessible online at: https://www.asn-online.org/education/kidneyweek/2023/program-search-ab ....
ASN Kidney Week attendees are also invited to visit the ProKidney booth (#938) during exhibit hours for additional information on REACT.
Poster Presentations
Renal autologous cell therapy (REACT) to delay dialysis in advanced CKD
Session Title: Diabetic Kidney Disease: Clinical - I
Session Date & Time: November 2, 2023, from 10:00 AM to 12:00 PM EDT
Poster Board #: TH-PO169
Selected Renal Cells Express a Podocyte-Parietal Epithelial Cell Transcriptome
Session Title: Glomerular Diseases: Podocyte Biology - I
Session Date, Time: November 2, 2023, from 10:00 AM to 12:00 PM EDT
Poster Board #: TH-PO739
Lesen Sie auch
Selected Renal Cells Exhibit Renal Tubule Formation Associated with Transforming Growth Factor B2 Expression
Session Title: Pediatric Nephrology - II
Session Date, Time: November 3, 2023, from 10:00 AM to 12:00 PM EDT
Poster Board #: FR-PO637
Selected Renal Cells Improve Renal Function in a Canine Model of Chronic Kidney Disease
Session Title: Development, Organoids, Vascularized Kidneys, Nephrons, and More
Session Date, Time: November 4, 2023, from 10:00 AM to 12:00 PM EDT
Poster Board #: SA-PO354
Publication Only
Osteopontin-Associated Reparative Effects of Selected Renal Cells
Abstract: PUB085
Selected Renal Cells Express Cell Adhesion Markers and Form Renal Tubules
Abstract: PUB086
Following the event, a copy of the poster presentations will be available on the Company’s website at https://investors.prokidney.com/news-events/events-and-presentations.
Additional information on ASN Kidney Week 2023 can be accessed online at https://www.asnonline.org/education/kidneyweek/.
About ProKidney
ProKidney, a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT (Renal Autologous
Cell Therapy), is a first-of-its-kind, patented, proprietary autologous cellular therapy being evaluated to potentially preserve kidney function in diabetic patients at high risk of kidney failure.
REACT has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program that launched in January 2022. For
more information, please visit www.prokidney.com.